Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
厄洛替尼（OSI-774）治疗转移性结直肠癌患者的II期研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6603055
Townsley, C A; Major, P; Siu, L L; Dancey, J; Chen, E; Pond, G R; Nicklee, T; Ho, J; Hedley, D; Tsao, M; Moore, M J; Oza, A M
